• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Inovio says COVID-19 vaccine candidate safe, effective in mid-stage trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 10, 2021 at 09:52: PM
via Inovio Pharmaceuticals Inc (INO.O) said its COVID-19 vaccine candidate was safe, well-tolerated and produced immune response against the new coronavirus in a mid-stage clinical trial, sending the drug developer's shares up over 3%.

article source
 




Similar threads

cafead
Inovio's COVID-19 vaccine funding axed as US says thanks but no thanks
Replies
0
Views
214
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Inovio's COVID-19 vaccine claims echo Theranos, says short attack
Replies
0
Views
109
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Inovio says no-go on phase 3 cervical lesion program after clinical setback, lays off 30%...
Replies
0
Views
73
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Inovio, with path to market opening up, drafts accelerated approval talking points ahead of...
Replies
0
Views
86
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Inovio’s HPV vaccine demonstrates immunological benefits in RRP
Replies
0
Views
147
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote